Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Ziconotide in Severe Chronic Pain
NCT00047749Phase 3Completed
- Sponsor
- Elan
- Start
- Aug 2002
- Modality
- Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of ziconotide in chronic pain, sponsored by Elan. Started Aug 2002; status: completed.
02
Drugs
ziconotide
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT00047749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00047749.